“prolonged fever” supervised by prof. achra sumboonnanonda md rattanavalai chantorn md paisarn...
TRANSCRIPT
“Prolonged fever”
Supervised byProf. Achra Sumboonnanonda MD
Rattanavalai Chantorn MDPaisarn Parichatiganond MD
Patient profile
12 years old Thai girl CC: Low grade fever for 1 month PTA Hx: 4 mo PTA She had persistent
erythematous rash on both cheeks and active hair loss. She came to a local hospital and was diagnosed as dermatitis.
1Mo PTA. She had low grade fever relieved by antipyretic drug.
She had no other symptoms except rash on her face that sometimes aggravated by sun exposure and increase excessive hair loss
3 wk PTA she became more malaise, pallor and went to private clinic. She received parenteral fluid and oral medications, the symptoms were partial improved.
2 wk PTA she still had persistent fever then she went to a local hospital.
At the hospitalPE: erythematous rash on malar
area The rash became worse and she
developed painful ulcer on her lips andoral mucosa, She also had erythematousmacules on her soles and swelling of her face
Investigation at the hospital-BUN/Cr 22/0.7 mg/dl-CBC: Hb 8 g/l, Hct 27 %, WBC 4,470 /mm3 (N75%, L20 %) Plt 196,000/mm3-Stool exam : WNL-UA : WNL-Urine culture: > 105 Streptococcus Gr. D, Enterococci spp
Rx :Ceftriaxone 2 gm OD x 9 d then Cefotaxime 1 gm IV q 6 hrs x
3d Doxycycline x 7d Gentamycin 100mg IV OD x 7d
Symptoms persisted then the patient was referred to “Siriraj hospital” Past history : healthy Family history : no family history of
atopy Drug history: analgesic drug allergy
Physical examination
V/S: T 38.3 oC, P110/min, R20/min, BP118/60 mmHg
BW 37.5 kg(P25-50), HT 155 cm(P50-75) GA: Irritable, look weak, not cooperative,
mildly pale, no jaundice, no dyspnea,dry lips, good skin turgor, no sunken eyeballs , capillary refill <2 sec, no eschar
HEENT: findings as figures
Bilateral scaly erythematous to brownish patches at malar eminence, nasal ridge and nasolabial folds,scaly edematous erythematous painful lips
RS: normal CVS: normal ABDOMEN: normal Extremities: Bilateral symmetrical
partially blanchable erythematous to purplish macules and papules on both palms and soles, no sign of joints inflammation
NS: normal No lymphadenopathy
CBC Hb 8.6 g/dl, Hct 26.9 %, MCV 71.7 fl, RDW
14.9 %, WBC 2,840 /mm3 (N 72.2, L 20.1), Platelets 198,000/mm3
HCMC RBC, no hemolytic blood pictureUrinalysis pH 7.0, Sp.Gr. 1.015, Protein +++,
Occult blood +, Bilirubin neg, Acetone neg, WBC 0-1/HF, RBC 1-2/HF, no cast and bacteria
Investigation
Blood chemistry BUN 13.0 mg/dl, Cr 0.5 mg/dl Na 135 mEq/dl, K 4.5 mEq/dl,
Cl 95 mEq/dl, HCO3- 19 mEq/dl
CXR WNLU/C, H/C : pending
Problem list
Prolonged fever for 4 weeks Active hair loss for 4 months Abnormal skin manifestation on scalp,
face, ears, lips, mouth and extremities Oral thrush Anemia: Hypochromic,microcytic Leukopenia and lymphopenia Proteinuria
Children with prolonged fever
Fever in this patient can be defined as fever of unknown origin (FUO)
The Petersdorf and Beeson criteria for FUO, definitionin1 9 6 1 are: ▪ a body temp ≥ 38.3°C for at least 3weeks;and ▪ 1failure to establish a diagnosis after weekoo oooooooooooooo
Differential diagnosis of FUO
Infection Autoimmune disease Neoplasm Miscellaneous (drug-related fever,
factitious fever, etc.)
Relation between infection and autoimmune disease
Clinical symptoms of infection may be indistinguishable from those of autoimmune disease
Immunosuppressive therapy for autoimmune disease may lead to increased susceptibility to infection
Infectious cause of FUO in children Salmonellosis Tuberculosis Rickettsial disease Bacterial endocarditis Infectious mononucleosis
Criteria of SLE
Malar rash Discoid rash Photosensitivity Oral ulcer Arthritis Serositis Renal disorder: persistent proteinuria Neurologic disorder: seizure, psychosis Hematologic disorder: hemolytic anemia,
leukopenia, lymphopenia, thrombocytopenia
Immunologic disorder: anti-dsDNA, anti-Sm, antiphospholipid antibody
ANA positive ACR 1982, updating classification criteria 1997
Characteristic of fever in active SLE disease Non-shaking fever Manifestation of active SLE: such
as Acute cutaneous LE Arthritis Hypertension, Edema Leukopenia with lymphopenia,
Thrombocytopenia
Study from department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
* **Suroj Supavekin MD ,Wanida Chatchomchuan MD , Anirut Pattaraga
* * *rn MD , Vibul Suntornpoch MD , Achra Sumboonnanonda MD *
-2005 88 8 11523J Med Assoc Thai ; (Suppl ): S From July 1985 to March 2003, 101 patients
The major clinical presentation of pediatric SLE are
- Renal (86.2%)- S kin and mucocutaneous (76.3%)
- hematological involvement (73.4%)
Pediatric Systemic Lupus Erythematosus in SirirajHospital
* **Suroj Supavekin MD ,Wanida Chatchomchuan MD ooooooooooo o o o o , * , * ,
*AchraSumboonnanonda MD *
-2005 88 8 115J Med Assoc Thai ; (Suppl ): S23
Signs and Symptoms at Diagnosis
Classification of lupus nephritis
Class I: Minimal mesangial LN Class II: Mesangial proliferative LN Class III: Focal LN Class IV: Diffused LN Class V: Membranous LN Class VI: Advanced sclerosis LN
International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003
Further investigation
Work up for source of infection KOH for oral thrush: Pseudohyphae with
budding yeast Stool concentration for parasite x 3days
negative Urine culture (10/4/50) No growth Hemoculture (10/4/50) No growth PPD skin test: Negative at 48, 72 hr Consult dentist: No dental caries
Further Investigation
peripheral blood smear (14/4/2550): hypochromic microcytic RBC, no anisopoikilocytosis, Plt 10-15/HPF
Reticulocyte count 0.61% Direct coomb’s test: negative Serum ferritin (17/4/2550): 1,537
(13-50)
“Iron deficiency anemia”
Further investigationAutoimmune profile ANA Positive
Positive with Fine-speckled pattern titer >1:2,560
Positive with Coarse-speckled pattern
Positive with Homogeneous pattern
Positive with Peripheral pattern
Positive with Anti-Cytoplasmic Ab
Anti-ds DNA Positive titer > 1:160 C3 level 36.8 (N 83-177) C4 level 6.56 (N 15-45)
Further investigation
Total protein 5.4 g/dl, Albumin 1.7 g/dl Urine Creatinine 28.3 mg/dl Urine Micro-TP148 mg/dl Urine protein/creatinine ratio 5 Urine protein 24 hr 55 mg/kg/d
“Nephrotic range proteinuria” Renal biopsy
Indication for kidney biopsy
All patient who correlate with criteria of LN
Nephrotic patient with undetermined diagnosed of Diffuse proliferative GN or Membranous GN
Patient whose renal function get worse despite of receiving high dose steroid
Fever and malaise:• Low dose NSAIDs with antimalarial drug or
low dose oral corticosteroid
Cutaneous lesion:• Sunblock cream with topical steroid and
antimalarial drug
Treatment of lupus nephritisBase on renal pathology
Class I: no treatment required Class II: short course treatment of low
dose steroid (prednisolone 0.5-1 MKD) Class III: prednisolone 1-2
MKD(max60mg/d) +immunosuppressive drug(Azathioprine 2MKD)
Class IV: prednisolone 2 MKD+pulse cyclophosphamide
Class Ⅴ: prednisolone 1-2 MKD Class Ⅵ:slow renal progression,aggressive
immunosuppressive drug not required
Progression
-Continue cefotaxime until 7days(10-13/4/50)-Cotrimazole troche to treat oral candiasis- Septic work up: all negative
so non-infectious cause is most likely
MedicationPrednisolone (2mg/kg/d)Hydroxychloroquine ( 5mg/kg/d)0.02%TA cream apply to lesions at face0.1% TA cream apply to lesions on scalp
Progression
Anemia:FeSO4 (200mg ) 1 tab PO tid pc
(5.6 mg/kg/day) (start 17/4/2550) New onset HT:BP 128/86(16/4/2550)
max135/73 mmHg (P95 124/81mmHg)- Enalapril (5mg) 1 tab PO OD pc
Follow up urinalysis 18/4/2550pH 7.0, sp.gr 1.010, protein neg, WBC 0-1,RBC neg, occult blood neg, others neg
Renal pathology
Mesangial hypercellularity and matrix expansion
No endocapillary proliferation No crescent Microthrombi in 1 arteriole
Imp: Lupus nephritis class II with thrombotic microangiopathy(TMA)
References• Suroj Supavekin MD,Wanida Chatchomchuan MD, Anirut
Pattaragarn MD, Vibul Suntornpoch MD, Achra Sumboon nanonda MD Study from department of Pediatrics,
Faculty of Medicine Siriraj Hospital, Mahidol University J -Med Assoc Thai 2005; 88(Suppl 8): S115 23
• The Subcommittee for Systemic Lupus Erythematosus Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7
• Wallco DJ, Halm BH, eds. Dubois’ lupus erythematosus. 5th edn. Baltimore: Williams and Wilkins, 1997